Skip to main content

Self-Imposed Use Cessation Dates Tied to Ophthalmic Drop Waste

Medically reviewed by Carmen Pope, BPharm. Last updated on July 16, 2024.

By Lori Solomon HealthDay Reporter

TUESDAY, July 16, 2024 -- Self-imposed use cessation dates (SUCD) for multiuse eye drop bottles leads to significant drug waste and associated costs, according to a report published online July 1 in Ophthalmology.

John M. Tan, from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues quantified the volume of drugs discarded in ambulatory clinic settings due to SUCD (discarded after 14 or 28 days) for multidose ophthalmic drops. Bottles slated for disposal at three 14-day intervals from three hospital-based ophthalmology clinics were analyzed for remaining volumes.

The researchers found that over six weeks, 297 bottles were discarded, with an average of 71.9 percent of the total volume of medication remaining in each bottle at the time it was discarded. The average time was 494 days between SUCDs and U.S. Food and Drug Administration-regulated expiration dates (FREDs; median, 533). Given the rate of usage, an estimated 91 percent of the discarded bottles would be fully depleted before expiration if FREDs were followed. An estimated 724,719 drops would be wasted over the year, translating to 188,647 encounters for proparacaine; 98,567 encounters for tropicamide; and 42,866 for phenylephrine. This yielded an extrapolated actual annual cost for eye drops of approximately $111,527.

“We are currently working with the Health System to consider using FDA-regulated expiration dates as the discard dates for our drops and have also instituted measures to reduce the number of bottles that are opened and ultimately wasted," coauthor Gareth Lema, M.D., PhD., also of the Icahn School of Medicine at Mount Sinai, said in a statement.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Ophthalmologic Manifestations of Acute Leukemia Are Heterogeneous

WEDNESDAY, July 17, 2024 -- Ophthalmologic manifestations of acute leukemia are heterogeneous and detectable at initial presentation or relapse, according to a study published...

Semaglutide Linked to Nonarteritic Anterior Ischemic Optic Neuropathy

WEDNESDAY, July 3, 2024 -- Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes (T2D) and those with...

Neighborhood Inequity Tied to More People Living With Vision Difficulty, Blindness

TUESDAY, May 14, 2024 -- Residential measures of inequity are associated with a greater number of individuals living with vision difficulty and blindness (VDB), according to a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.